Sansure Biotech Inc. (SHA:688289)
China · Delayed Price · Currency is CNY 16.72
+0.45 (2.77%)
Sep 30, 2026, 3:00 PM CST
Sansure Biotech Market Cap
Sansure Biotech has a market cap or net worth of 9.5 billion as of October 6, 2026. Its market cap has decreased by -19.38% in one year.
Market Cap
9.50B
Enterprise Value
7.28B
Revenue
1.61B
Ranking
n/a
PE Ratio
72.60
Stock Price
16.72
ChartMarket Cap Chart
Since August 28, 2020, Sansure Biotech's market cap has decreased from 46.42B to 9.50B, a decrease of -79.54%. That is a compound annual growth rate of -22.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 9.50B | -12.52% |
| Dec 31, 2025 | 10.86B | -16.48% |
| Dec 31, 2024 | 13.00B | 16.22% |
| Dec 29, 2023 | 11.19B | -12.24% |
| Dec 30, 2022 | 12.75B | -45.99% |
| Dec 31, 2021 | 23.60B | -48.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hualan New Pharmaceutical Material | 13.44B |
| Shenyang Xingqi Pharmaceutical | 13.02B |
| Tofflon Science and Technology Group | 12.50B |
| Autek China | 9.10B |
| Zhonghong Pulin Medical Products | 8.68B |
| Caina Technology | 8.15B |
| Eyebright Medical Technology (Beijing) | 7.51B |
| Aidite (Qinhuangdao) Technology | 7.48B |